Article
In vivo bioassay to test the pathogenicity of missense human AIP variants.
Journal of medical genetics - 1 Aug 2018
Aflorei Elena Daniela, Klapholz Benjamin, Chen Chenghao, Radian Serban, Dragu Anca Neluta, Moderau Nina, Prodromou Chrisostomos, Ribeiro Paulo S, Stanewsky Ralf, Korbonits Márta
Abstract excerpt
BACKGROUND: Heterozygous germline loss-of-function mutations in the aryl hydrocarbon receptor-interacting protein gene (AIP) predispose to childhood-onset pituitary tumours. The pathogenicity of missense variants may pose difficulties for genetic counselling and family follow-up. OBJECTIVE: To develop an in vivo system to test the pathogenicity of human AIP mutations using the fruit fly Drosophila melanogaster....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
